We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · October 13, 2021

Erythrocytosis and Thromboembolic Events in Transgender Patients on Testosterone

Thrombosis Research


Additional Info

Thrombosis Research
Erythrocytosis and thromboembolic events in transgender individuals receiving gender-affirming testosterone
Thromb. Res. 2021 Sep 20;[EPub Ahead of Print], M Oakes, A Arastu, C Kato, J Somers, HD Holly, BK Elstrott, GW Dy, TCL Kohs, RR Patel, OJT McCarty, TG DeLoughery, C Milano, V Raghunathan, JJ Shatzel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading